261 related articles for article (PubMed ID: 22399508)
21. [Micromedullary thyroid carcinoma: school experience].
Palermo S; Di Matteo FM; Savino G; Di Marco C; Catania A; De Antoni E
G Chir; 2010; 31(6-7):299-302. PubMed ID: 20646376
[TBL] [Abstract][Full Text] [Related]
22. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
23. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
Machens A; Hinze R; Thomusch O; Dralle H
World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
[TBL] [Abstract][Full Text] [Related]
24. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
25. Medullary thyroid carcinoma in Hong Kong Chinese patients.
Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
[TBL] [Abstract][Full Text] [Related]
26. Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening.
Machens A; Dralle H
Eur J Endocrinol; 2016 Sep; 175(3):219-28. PubMed ID: 27334331
[TBL] [Abstract][Full Text] [Related]
27. Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.
Aubert S; Berdelou A; Gnemmi V; Behal H; Caiazzo R; D'herbomez M; Pigny P; Wemeau JL; Carnaille B; Renaud F; Bouchindhomme B; Leteurtre E; Perrais M; Pattou F; Do Cao C
Virchows Arch; 2018 Mar; 472(3):461-468. PubMed ID: 29388012
[TBL] [Abstract][Full Text] [Related]
28. Benefit-risk balance of reoperation for persistent medullary thyroid cancer.
Machens A; Dralle H
Ann Surg; 2013 Apr; 257(4):751-7. PubMed ID: 23023200
[TBL] [Abstract][Full Text] [Related]
29. [Surgical management of medullary thyroid carcinoma. Personal experience].
Geraci G; Pisello F; Tornambè A; Platia L; Sciumè C; Li Volsi F; Cupido F; Modica G
G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
[TBL] [Abstract][Full Text] [Related]
30. Lymph node involvement in macroscopic medullary thyroid carcinoma.
Tamagnini P; Iacobone M; Sebag F; Marcy M; De Micco C; Henry JF
Br J Surg; 2005 Apr; 92(4):449-53. PubMed ID: 15672437
[TBL] [Abstract][Full Text] [Related]
31. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases.
Etit D; Faquin WC; Gaz R; Randolph G; DeLellis RA; Pilch BZ
Arch Pathol Lab Med; 2008 Nov; 132(11):1767-73. PubMed ID: 18976013
[TBL] [Abstract][Full Text] [Related]
32. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
34. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
35. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma.
Hamy A; Pessaux P; Mirallié E; Mucci-Hennekinne S; Gibelin H; Mor-Martinez C; de Calan L; Ronceray J; Kraimps JL
Eur J Surg Oncol; 2005 Sep; 31(7):774-7. PubMed ID: 15925476
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma.
Brauckhoff M; Lorenz K; Ukkat J; Brauckhoff K; Gimm O; Dralle H
Scand J Surg; 2004; 93(4):249-60. PubMed ID: 15658665
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
38. Fewer cancer reoperations for medullary thyroid cancer after initial surgery according to ATA guidelines.
Verbeek HH; Meijer JA; Zandee WT; Kramp KH; Sluiter WJ; Smit JW; Kievit J; Links TP; Plukker JT
Ann Surg Oncol; 2015 Apr; 22(4):1207-13. PubMed ID: 25316487
[TBL] [Abstract][Full Text] [Related]
39. Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Br J Surg; 2004 Jun; 91(6):709-12. PubMed ID: 15164439
[TBL] [Abstract][Full Text] [Related]
40. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Machens A; Ukkat J; Hauptmann S; Dralle H
Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]